Relevant bibliographies by topics / Antisecretory drug

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters

Academic literature on the topic 'Antisecretory drug'

Author: Grafiati
Published: 5 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antisecretory drug.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antisecretory drug"

1

HANSTEN, P. D. "Drug interactions with antisecretory agents." Alimentary Pharmacology & Therapeutics 5 (March 31, 2007): 121–28. http://dx.doi.org/10.1111/j.1365-2036.1991.tb00755.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zwisler, Jon Eik, Dorte Ejg Jarbøl, Annmarie Touborg Lassen, Jakob Kragstrup, Niels Thorsgaard, and Ove B. Schaffalitzky de Muckadell. "Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice." International Journal of Family Medicine 2015 (July 12, 2015): 1–7. http://dx.doi.org/10.1155/2015/175436.

Full text
Abstract:
Objective. To investigate whether patients on long-term antisecretory medication need to continue treatment to control symptoms. Methods. A double-blinded randomised placebo-controlled trial in general practices in Denmark. Patients aged 18–90 who were treated with antisecretory drugs on a long-term basis were randomized to esomeprazole 40 mg or identical placebo. Outcome measures were time to discontinuation with trial medication due to failed symptom control analysed as survival data. The proportion of patients stopping trial medication during the one-year follow-up was estimated. Results. A
APA, Harvard, Vancouver, ISO, and other styles
3

Lopina, O. D., B. K. Nurgalieva, and T. L. Lapina. "Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole." Russian Journal of Gastroenterology, Hepatology, Coloproctology 31, no. 4 (2021): 55–63. http://dx.doi.org/10.22416/1382-4376-2021-31-4-55-63.

Full text
Abstract:
Aim. A comparative review of the rabeprazole properties vs. other PPIs, its efficacy and safety in treatment for aciddependent diseases.Key points. Rabeprazole provides a rapid proton pump blockade in parietal cells due to its high dissociation constant (pKa). A lower rabeprazole metabolic dependence on cytochrome P-450 enzyme system renders its antisecretory effect predictable and reduces the risk of interactions with other drugs metabolised through this system. A faster antisecretory effect and higher acid-suppressive activity of rabeprazole determine its better clinical efficacy in treatmen
APA, Harvard, Vancouver, ISO, and other styles
4

Lazzaroni, M., O. Sangaletti, and G. Bianchi Porro. "The Effect of a Single Oral Morning Dose of Nizatidine and Ranitidine on Intragastric pH under Basal Conditions and after Pentagastrin Stimulation." Journal of International Medical Research 20, no. 6 (1992): 454–60. http://dx.doi.org/10.1177/030006059202000602.

Full text
Abstract:
A comparison was made of the antisecretory activity of orally administered nizatidine and ranitidine by measuring intragastric pH under basal conditions and during and after pentagastrin stimulation. Intragastric pH values were measured with a bipolar glass electrode in 10 patients with healed duodenal ulcers treated with nizatidine or ranitidine according to a randomized single-blind design. The antisecretory activity of the two drugs was similar during the 4 h of monitoring following drug administration. Nizatidine, however, showed a more rapid inhibitory action than ranitidine, producing a
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Drug interactions with antisecretory agents are examined." Reactions Weekly &NA;, no. 369 (1991): 3–4. http://dx.doi.org/10.2165/00128415-199103690-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Krivopalov, A. A., S. V. Ryazansev, and P. A. Shamkina. "Complex homeopathic therapy of acute infectious rhinitis." Meditsinskiy sovet = Medical Council, no. 8 (April 18, 2019): 38–42. http://dx.doi.org/10.21518/2079-701x-2019-8-38-42.

Full text
Abstract:
The article is devoted to the use of the combined drug Coryzalia in the treatment of acute rhinitis. The advantages of Coryzalia are the possibility of using it at any stage of treatment, combination with other drugs. The complex of active ingredients that make up the drug, has anti-inflammatory, antisecretory and detoxifying effects. The results of various studies confirm the high safety profile and efficacy of Coryzalia not only for adults, but also for treatment of children.
APA, Harvard, Vancouver, ISO, and other styles
7

Locci, Cristian, Laura Cuzzolin, Gianluca Cheri, Laura Saderi, Giovanni Sotgiu, and Roberto Antonucci. "Clinical Use of Gastric Antisecretory Drugs in Hospitalized Pediatric Patients." Journal of Clinical Medicine 12, no. 1 (2023): 368. http://dx.doi.org/10.3390/jcm12010368.

Full text
Abstract:
Antisecretory drugs are frequently used in the treatment of pediatric gastrointestinal disorders. This study was aimed to assess the prescribing patterns and the safety of ranitidine and proton pump inhibitors (PPIs) in a cohort of Italian pediatric patients. Children aged >1 month to <16 years that were admitted to our Pediatric Clinic between 2016 and 2018 were enrolled in this retrospective observational study. All data were obtained from medical records and a parent telephone questionnaire. The exclusion criteria included the use of antisecretory therapy at hospital admission, failur
APA, Harvard, Vancouver, ISO, and other styles
8

Chernikov, M. V., M. A. Oganova, A. S. Gerasimenko, and E. A. Artemyev. "STUDY OF ANTISECRETORY ACTIVITY OF DINITRATE 2-PHENYL-9-DIETHYLAMINOETHYLimidazo[1,2-A] BENZIMIDAZOLE BY METHOD OF CONTINUOUS PERFUSION OF RATS’ STOMACHS." Pharmacy & Pharmacology 7, no. 4 (2019): 231–40. http://dx.doi.org/10.19163/2307-9266-2019-7-4-231-240.

Full text
Abstract:
Nowadays, effective pharmacotherapy of acid-dependent gastrointestinal diseases remains an urgent problem of modern gastroenterology. In this regard, the search for new drugs with a pronounced antisecretory activity still continues; their aim is to keep the control over the acid production safe and effective.The aim of this study was an experimental study of the antisecretory activity of the substance and the finished dosage form (FDF) of dinitrate 2-phenyl-9-diethylaminoethylimidazo[1,2-a]benzimidazole.Materials and Methods. The study of antisecretory activity was performed by method of a con
APA, Harvard, Vancouver, ISO, and other styles
9

Saeed, Zahid A., Jeffrey A. Norton, William O. Frank, et al. "Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome." Gastroenterology 96, no. 6 (1989): 1393–402. http://dx.doi.org/10.1016/0016-5085(89)90504-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jones, James B., and Robert T. Bailey. "Misoprostol: A Prostaglandin E, Analog with Antisecretory and Cytoprotective Properties." DICP 23, no. 4 (1989): 276–82. http://dx.doi.org/10.1177/106002808902300401.

Full text
Abstract:
Misoprostol, a methylester analog of prostaglandin E1, with antisecretory and cytoprotective properties, has undergone extensive investigation and has received Food and Drug Administration approval for the prevention of nonsteroidal-induced ulceration. The drug represents the first synthetic, orally active prostaglandin evaluated for the treatment of peptic ulcer disease. Clinical studies reveal a trend toward slightly lower healing rates with misoprostol when compared with histamine (H2)-receptor antagonists in the treatment of gastric and duodenal ulcers. In addition, misoprostol was less ef
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Antisecretory drug"

1

Panter, Simon J. "Oesophago-gastric cancer : factors influencing presentation and the effects of antisecretory drug therapy on symptoms and diagnosis." Thesis, University of Edinburgh, 2008. http://hdl.handle.net/1842/29311.

Full text
Abstract:
Methods: A retrospective cohort study of 685 patients with oesophago-gastric adenocarcinoma (ACA) diagnosed in South Tees between April 1991-2001 and prospective studies of gastric ulcer disease and chromoendoscopy. Results: The time course to diagnosis was determined and showed a mean time to diagnosis of 30 weeks. Patients with oesophageal cancer took longer to present to their GP and longer to be seen in secondary care once referred. The part of the diagnostic process in primary care was double that in secondary care. Antisecretory drug therapy (AST) prescribed prior to endoscopy resulted i
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Antisecretory drug"

1

Hannan, M. Ashraful. Application of the pH feed-back regulated microinfusion pump and the production of gastric anacidity with antisecretory drugs. University of Birmingham, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Annotated bibliography on antisecretory agents in the treatment of diarrhoeal diseases. International Centre for Diarrhoeal Disease Research, Bangladesh, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Antisecretory drug"

1

Howden, C. W., and R. H. Hunt. "Development of a New Gastric Antisecretory Drug for Clinical Use." In Pharmacology of Peptic Ulcer Disease. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-75858-4_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Smolić, Robert, Sonja Vukadin, and Lucija Kuna. "Antisecretory Drugs." In Clinical Gastroenterology. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-69800-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Scarpignato, C., and I. Pelosini. "Antisecretory Drugs for Eradication of Helicobacter pylori: Antibacterial Activity and Synergism with Antimicrobial Agents." In Clinical Pharmacology and Therapy of Helicobacter pylori Infection. KARGER, 1999. http://dx.doi.org/10.1159/000061964.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Scarpignato, C., and I. Pelosini. "Antisecretory Drugs for Eradication of Helicobacter pylori: Antibacterial Activity and Synergism with Antimicrobial Agents." In Clinical Pharmacology and Therapy of Helicobacter pylori Infection. KARGER, 2004. http://dx.doi.org/10.1159/000077620.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Welcome, Menizibeya Osain. "Gastrointestinal Exocrine (Lumencrine) Secretions. The Reception Theory as the Basis for Developing the First Antisecretory Pharmacotherapy Drugs." In Gastrointestinal Physiology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-91056-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chattri, GL. "Antiulcers/Antisecretory." In Pediatric Drug Doses. Jaypee Brothers Medical Publishers (P) Ltd., 2012. http://dx.doi.org/10.5005/jp/books/11551_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chattri, GL. "Antiulcers/Antisecretory." In Pediatric Drug Doses. Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12718_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chattri, GL. "Antiulcers/Antisecretory." In Pediatric Drug Doses. Jaypee Brothers Medical Publishers (P) Ltd., 2010. http://dx.doi.org/10.5005/jp/books/11265_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Antisecretory drug' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography